Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2004 1
2007 1
2008 1
2009 1
2010 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hr vs bisphosphonates bone density (61 results)?
Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate.
Trombetti A, Gerbase MW, Spiliopoulos A, Slosman DO, Nicod LP, Rizzoli R. Trombetti A, et al. J Heart Lung Transplant. 2000 Aug;19(8):736-43. doi: 10.1016/s1053-2498(00)00132-7. J Heart Lung Transplant. 2000. PMID: 10967266 Clinical Trial.

At that time, 29% were osteoporotic (T-score < - 2.5 below the peak bone mass), while 55% were below - 1.0 T-score. Antiresorptive therapy decreased the rate of LS bone loss during the first 6 months and led to a significant increase of BMD at 1 year, with LS cha

…

At that time, 29% were osteoporotic (T-score < - 2.5 below the peak bone mass), while 55% were below - 1.0 T-score. Antiresorptive

…
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S. Tuppurainen M, et al. Maturitas. 2010 Aug;66(4):423-30. doi: 10.1016/j.maturitas.2010.04.013. Epub 2010 May 23. Maturitas. 2010. PMID: 20547017 Clinical Trial.
OBJECTIVE: To determine the effects of HRT with or without clodronate on bone mineral density (BMD) change and bone turnover markers. ...CONCLUSIONS: In postmenopausal women with osteoporosis, HRT increased spinal and femoral BMD, but the combin …
OBJECTIVE: To determine the effects of HRT with or without clodronate on bone mineral density (BMD) change and bone …
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial.
Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, Liss CL, Melton ME, Byrnes CA. Lindsay R, et al. J Clin Endocrinol Metab. 1999 Sep;84(9):3076-81. doi: 10.1210/jcem.84.9.5989. J Clin Endocrinol Metab. 1999. PMID: 10487668 Clinical Trial.
HRT was continued in both groups. Changes in bone mineral density (BMD) and biochemical markers of bone turnover were assessed. ...This study demonstrated that, in postmenopausal women with low bone density despite ongoing treatment with …
HRT was continued in both groups. Changes in bone mineral density (BMD) and biochemical markers of bone turnover …
Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial.
Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM; Research Committee of the British Thoracic Society. Campbell IA, et al. Scott Med J. 2009 Feb;54(1):21-5. doi: 10.1258/rsmsmj.54.1.21. Scott Med J. 2009. PMID: 19291931 Clinical Trial.
The trial was multi-centre and aimed to recruit 750 patients. Outcomes were fractures and changes in bone mineral density (BMD). RESULTS: For reasons detailed in the discussion section of the text, only 50 patients were entered. ...New or worsening morphometric frac …
The trial was multi-centre and aimed to recruit 750 patients. Outcomes were fractures and changes in bone mineral density (BMD …
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C. Saarto T, et al. Br J Cancer. 2001 Apr 20;84(8):1047-51. doi: 10.1054/bjoc.2001.1729. Br J Cancer. 2001. PMID: 11308252 Free PMC article. Clinical Trial.
All patients were disease-free at the time of BMD measurements. Patients who had recently used HRT had more significant bone loss as compared to HRT non-users at 3 years in lumbar spine - 3.0% vs. + 1.2% (P< 0.001), but not in femoral neck - 0.4% …
All patients were disease-free at the time of BMD measurements. Patients who had recently used HRT had more significant bone l …
Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.
Eviö S, Tiitinen A, Laitinen K, Ylikorkala O, Välimäki MJ. Eviö S, et al. J Clin Endocrinol Metab. 2004 Feb;89(2):626-31. doi: 10.1210/jc.2003-030198. J Clin Endocrinol Metab. 2004. PMID: 14764773 Clinical Trial.
Ninety patients, aged 65-80 yr (mean 71), with a T-score of bone mineral density (BMD) of 2.5 or less at either the lumbar spine or the femoral neck were randomized to receive daily 10 mg alendronate (n = 30), 2 mg estradiol plus 1 mg norethisterone acetate (n = 30) …
Ninety patients, aged 65-80 yr (mean 71), with a T-score of bone mineral density (BMD) of 2.5 or less at either the lumbar spi …
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
Byrjalsen I, Leeming DJ, Qvist P, Christiansen C, Karsdal MA. Byrjalsen I, et al. Osteoporos Int. 2008 Mar;19(3):339-48. doi: 10.1007/s00198-007-0462-5. Epub 2007 Sep 11. Osteoporos Int. 2008. PMID: 17846859 Clinical Trial.
RESULTS: Bone collagen maturation measured as the ratio between alphaalphaCTX and betabetaCTX showed that bisphosphonate treatment induced a collagen profile consistent with an older matrix with a 52% (alendronate) and 38% (ibandronate) reduction in the ratio betwee …
RESULTS: Bone collagen maturation measured as the ratio between alphaalphaCTX and betabetaCTX showed that bisphosphonate treat …